Perigrine Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.44 M
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
About Perigrine Pharmatech
Perigrine Pharmatech Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 September 1995 and has a history of 29 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.44 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Chhajed, Vinod Chhajed, Mukund Ghaisas, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1995PTC092386
-
Company No.
092386
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Sep 1995
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Perigrine Pharmatech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Chhajed
|
Director | 10-May-2017 | Current |
|
Ashok Chhajed
|
Director | 01-Nov-2002 | Current |
|
Mukund Ghaisas
|
Director | 31-Oct-1997 | Current |
|
Shrikant Chilekar
|
Director | 31-Oct-1997 | Current |
Financial Performance of Perigrine Pharmatech.
Perigrine Pharmatech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Perigrine Pharmatech?
In 2017, Perigrine Pharmatech had a promoter holding of 66.66% and a public holding of 33.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Wintech Pharmaceuticals LimitedAshok Chhajed is a mutual person
-
Welcome Distributors Private LimitedMukund Ghaisas and Shrikant Chilekar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Perigrine Pharmatech?
Unlock and access historical data on people associated with Perigrine Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Perigrine Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perigrine Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.